Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials
Translational Oncogenomics · 2015
DOI: 10.4137/tog.s30533 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Oncogenomics, 2015. Verfasst von Juanita Lopez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, UK.
Zitieren
APA
Lopez, J., Harris, S., Roda, D., & Yap, T. A. (2015). Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials. Translational Oncogenomics. https://doi.org/10.4137/tog.s30533
Vancouver
Lopez J, Harris S, Roda D, Yap TA. Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials. Translational Oncogenomics. 2015. doi:10.4137/tog.s30533
BibTeX
@article{Lopez2015,
author = {Lopez, Juanita and Harris, Sam and Roda, Desam and Yap, Timothy A},
title = {Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials},
journal = {Translational Oncogenomics},
year = {2015},
doi = {10.4137/tog.s30533}
}
EUVIMED